Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction

This publication has 29 references indexed in Scilit:

• SIMULTANEOUS MEASUREMENT BY HIGH PERFORMANCE LIQUID (HPLC) CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION OF FOUR HIV PROTEASE INHIBITORS IN PLASMA FROM HIV INFECTED INDIVIDUALS - APPLICATION TO THERAPEUTIC DRUG MONITORING (TDM).
  Therapeutic Drug Monitoring, 1999
• PHARMACOKINETIC PROFILE OF NELFINAVIR (NFV) AND EFAVIRENZ (EFV) IN COMBINATION THERAPY ADMINISTERED TO HIV-1 INFECTED PATIENTS.
  Therapeutic Drug Monitoring, 1999
• SIMULTANEOUS DETERMINATION OF INDINAVIR, RITONAVIR, SAQUINAVIR, AND NELFINAVIR BY HPLC
  Therapeutic Drug Monitoring, 1999
• Efavirenz
  Drugs, 1998
• Simultaneous Determination of Unlabeled and Deuterium-Labeled Indinavir in Human Plasma by High-Performance Liquid Chromatography with Tandem Mass Spectrometric Detection
  Journal of Pharmaceutical Sciences, 1997
• Determination of L-735 524, an human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switching
  Journal of Chromatography A, 1995
• Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies
  European Journal of Drug Metabolism and Pharmacokinetics, 1991
• Simultaneous quantification of zidovudine and its glucuronide in serum by high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1988
• Inactivation of human T‐cell lymphotropic virus, type III by heat, chemicals, and irradiation
  Transfusion, 1986
• Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.
  Journal of Clinical Investigation, 1985